Bank OZK enters the August stretch with a striking disconnect at its core: short sellers hold a 13.5% position in the regional lender's free float — one of the heaviest bearish bets in its peer group — yet the mechanics required for a squeeze simply aren't there.
Short interest is the defining feature of the OZK story right now. At 13.5% of free float, the position has grown 6.5% over the past month and 0.25% on the week, reaching roughly 15.2 million shares. The FINRA-reported fortnightly figure, settled to mid-July, put short shares even higher at 15.8 million with a days-to-cover reading of 10.75 — meaning shorts would need nearly two trading weeks to cover at current volumes. That's a structurally crowded position by any regional bank standard. Peers HWC, VLY, and ZION all posted modest weekly gains of 0.8–1.8%, drifting higher while OZK gained just 0.2% over the same period.
The borrow market tells a very different story, and the contrast matters. Availability is running at 837% — meaning roughly eight shares are available to borrow for every one already shorted — and cost to borrow has eased to 0.43%, down on the week and sitting near its cheapest level in six months. The ORTEX short score of 66.2 has been essentially flat for a week, ticking marginally higher but showing no acceleration. That combination — heavy SI, loose borrow, flat short score — points to a position that is entrenched rather than escalating. Options sentiment has turned notably less defensive this week: the put/call ratio dropped sharply to 1.18, more than three standard deviations below its 20-day average of 1.34, its lowest reading in months. Call demand is rising relative to puts, which cuts against the bearish narrative embedded in the short book.
The Street is cautiously neutral, and recent analyst action reflects that stance. UBS lifted its target to $51 this week — just barely above the current price of $51.41 — while maintaining a Neutral rating. TD Cowen trimmed its target to $52 after downgrading OZK from Buy to Hold in early July. Morgan Stanley has an Equal-Weight with a $56 target set in late June. The mean target across the Street is $54.22, implying about 5% upside. On valuation, OZK trades at a P/E of 8.6 and a price-to-book of 0.87, the latter having moved less than 3% over the past month — this is a cheap bank, but the Street is not willing to pay up for it. The ORTEX short score rank places OZK in the bottom 1% of the universe on short positioning intensity, while the days-to-cover rank sits in the 13th percentile — telling you the bearish bet is outsized but not mechanically stressed.
The bull case rests on OZK's demonstrated earnings resilience: 12.1% tangible book value per share growth, a 1.75% return on assets, and mid-single-digit loan growth guided for 2026 accelerating toward 10–11% in 2027. The bear case centres on credit quality — specifically whether the bank's heavy commercial real estate and construction loan book suffers in a slowdown — combined with net interest margin compression risk if rates fall. Institutional holders are broadly passive; Dimensional recently added a modest 38,592 shares, and Geode added over one million, while Millennium trimmed by 171,525. No single active manager is making a directional statement of consequence. Insider activity over the past 90 days produced a small net buy of 6,644 shares worth roughly $336,000, though that number is flattered by an independent director's purchase in March and offset by modest executive sales, most recently the General Counsel selling in mid-June.
Earnings history adds context without comfort: OZK fell 1.3% on the day after each of its two most recent prints. The next result is not due until October 22. Between now and then, the tension worth watching is whether the short position begins to cover as borrow remains cheap and call demand builds — or whether credit-quality headlines reignite the bear thesis before the next earnings window opens.
See the live data behind this article on ORTEX.
Open OZK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.